The localization of the relaxed form of plasminogen activator inhibitor type 2 in human gingival tissues

Histochemistry and Cell Biology

Volumn 116, Issue 5, 2001, Pages 447-452

  Lindberg, Pia ^a   Baker, Mark S ^b   Kinnby, Bertil ^a  

^a MALMÖ UNIVERSITY   (Sweden)

^b ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Gingival tissue; Plasminogen activator inhibitors; Plasminogen activators; Proteolysis; Relaxed PAI 2

Indexed keywords

MONOCLONAL ANTIBODY; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEINASE;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FROZEN SECTION; GINGIVA; GINGIVITIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN INTERACTION; TISSUE DISTRIBUTION;

ANTIBODIES, MONOCLONAL; BIOPSY; BLOTTING, WESTERN; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GINGIVA; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; IMMUNOHISTOCHEMISTRY; PLASMINOGEN ACTIVATOR INHIBITOR 2;

EID: 0035215417     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-001-0341-7     Document Type: Article

References (30)

1. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator
2. Urokinase-producing tumour growth in SCID mice inhibited by recombinant PAI-2
3. Plasminogen activator inhibitor type 2 in the lesional epidermis of lupus erythematosus
4. The plasminogen (fibrinolytic) system
5. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis
6. Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor
7. Structure and mechanism of action of serpins
8. An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture
9. Implications of the three-dimensional structure of alpha1-antitrypsin for structure and function of serpins
10. A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking
11. Plasminogen activator inhibitor type 2: An intracellular keratinocyte differentiation product that is incorporated into the cornified envelope
12. The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain
13. Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid
14. Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival fluid from 8-9-year-old children
15. The plasminogen-activating system in gingival fluid from adults. An intra-individual study before and after treatment of gingivitis
16. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid
17. Localization of plasminogen activators and plasminogen activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization
18. Biological and clinical aspects of plasminogen activator inhibitor type 2
19. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type 2
20. Localization of plasminogen activator inhibitor type 2 (PAI-2) in hair and nail: Implications for terminal differentiation
21. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma
22. Plasminogen activators and plasminogen activator inhibitors: Biochemical aspects
23. Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes
24. Secretion of plasminogen activator inhibitor 2 by human peripheral blood monocytes occurs via an endoplasmic reticulum-Golgi-independent pathway
25. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen)
26. Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2
27. Tissue-specific expression of the relaxed conformation of plasminogen activator inhibitor-2 and low-density lipoprotein receptor-related protein in human term gestational tissues
28. Plasminogen activator inhibitor type 2 in human corneal epithelium
29. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages
30. Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells